Lameness associated with tarsal haemarthrosis as the sole clinical sign of idiopathic immune-mediated thrombocytopenia in a dog

M. B. Walton; E. Mardell; M. Spoor; J. Innes

doi:10.3415/VCOT-14-03-0041

Veterinary and Comparative Orthopaedics and Traumatology, Table of Contents

Vet Comp Orthop Traumatol 2014; 27(06): 491-495
DOI: 10.3415/VCOT-14-03-0041

Case Report

Schattauer GmbH

Lameness associated with tarsal haemarthrosis as the sole clinical sign of idiopathic immune-mediated thrombocytopenia in a dog

Authors

M. B. Walton

¹Chestergates Veterinary Specialists, Department of Orthopaedics, Chester, Cheshire, UK
E. Mardell

²Chestergates Veterinary Specialists, Department of Medicine, Chester, Cheshire, UK
M. Spoor

³Axiom Veterinary Laboratories, Newton Abbot, Devon, UK
J. Innes

¹Chestergates Veterinary Specialists, Department of Orthopaedics, Chester, Cheshire, UK

Abstract

Summary

A four-year-old, male Cocker Spaniel was presented for investigation of pelvic limb stiffness. There was palpable effusion of both tarsi, and analysis of synovial fluid from these joints indicated previous haemorrhage. After further investigation a diagnosis of idiopathic immune-mediated thrombocytopenia was made. The dog responded to treatment with prednisolone and azathioprine. To the authors’ knowledge, this is the first reported case of confirmed haemarthrosis as the sole presenting clinical sign for canine idiopathic immunemediated thrombocytopenia.

Keywords

Haemarthrosis - idiopathic immunemediated thrombocytopenia - lameness

Full Text

References

References
1 Botsch V, Küchenhoff H, Hartmann K. et al. Retrospective study of 871 dogs with thrombocytopenia. Vet Rec 2009; 64: 647-651
2 Wilkins RJ, Hurvitz AI, Dodds-Laffin WJ. Immunologically mediated thrombocytopenia in the dog. J Am Vet Med Assoc 1973; 163: 277-282
3 Williams DA, Maggio-Price L. Canine idiopathic thrombocytopenia: clinical observations and long-term follow-up in 54 cases. J Am Vet Med Assoc 1984; 185: 660-664
4 Jackson ML, Kruth SA. Immune-mediated hemolytic anemia and thrombocytopenia in the dog: a retrospective study of 55 cases diagnosed from 1979 through 1983 at the Western College of Veterinary Medicine. Can Vet J 1985; 26: 245-250
5 Lewis DC, Meyers KM. Canine idiopathic thrombocytopenic purpura. J Vet Intern Med 1996; 10: 207-218
6 Putsche JC, Kohn B. Primary immune-mediated thrombocytopenia in 30 dogs (1997-2003). J Am Anim Hosp Assoc 2008; 44: 250-257
7 Hercock CA, Pinchbeck G, Giejda A. et al. Validation of a client-based clinical metrology instrument for the evaluation of canine elbow osteoarthritis. J Small Anim Pract 2009; 50: 266-271
8 Walton MB, Cowderoy E, Lascelles D. et al. Evaluation of construct and criterion validity for the “Liverpool Osteoarthritis in Dogs” (LOAD) clinical metrology instrument and comparison to two other instruments. PLoS ONE 2013; 8: e58125.
9 Clements DN, Gear RNA, Tattersall J. et al. Type I immune-mediated polyarthritis in dogs: 39 cases (1997-2002). J Am Vet Med Assoc 2004; 224: 1323-1327
10 Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost 2010; 8: 1895-1902
11 van Meegeren ME, Roosendaal G, Barten-van Rijbroek AD. et al. Coagulation aggravates blood-induced joint damage in dogs. Arthritis Rheum 2012; 64: 3231-3239
12 øvlisen K, Kristensen AT, Jensen AL. et al. IL-1 beta, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis. Haemophilia 2009; 15: 802-810
13 Bellah JR, Weigel JP. Hemarthrosis secondary to suspected warfarin toxicosis in a dog. J Am Vet Med Assoc 1983; 182: 1126-1127
14 Johnstone IB, Norris AM. A moderately severe expression of classical hemophilia in a family of german shepherd dogs. Can Vet J 1984; 25: 191-194
15 Lobetti RG, Dippenaar T. Von Willebrand's disease in the German shepherd dog: clinical communication. J S Afr Vet Assoc 2000; 71: 118-121
16 Gallagher B, Brennan SF, Zarelli M. et al. Geographical, clinical, clinicopathological andradiographic features of canine angiostrongylosis in Irish dogs: a retrospective study. Ir Vet J 2012; 65: 5.
17 Moller DE, Goldstein K. Hemarthrosis and idiopathic thrombocytopenic purpura. J Rheumatol 1987; 14: 382-383
18 O'Marra SK, Delaforcade AM, Shaw SP. Treatment and predictors of outcome in dogs with immune-mediated thrombocytopenia. J Am Vet Med Assoc 2011; 238: 346-352
19 United Kingdom Haemophilia Centre Doctors's Association. Annual Report 2012 UK National Haemophilia Database Bleeding Disorder Statistics for 2011-2012. Bleeding Disorder Statistics for April 2011 to March 2012 [cited in 2014]. Available from http://www.ukhcdo.org/annReport.htm
20 Roosendaal G, Vianen ME, van den Berg HM. et al. Cartilage damage as a result of hemarthrosis in a human in vitro model. J Rheumatol 1997; 24: 1350-1354
21 Hooiveld M, Roosendaal G, Wenting M. et al. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 2003; 162: 943-951
22 Jansen NWD, Roosendaal G, Bijlsma JWJ. et al. Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: An in vitro study. Arthritis Rheum 2006; 56: 199-207
23 Wolf CR, Mankin HJ. The effect of experimental hemarthrosis on articular cartilage of rabbit knee joints. J Bone Joint Surg Am 1965; 47: 1203-1210
24 Hoaglund FT. Experimental hemarthrosis. The response of canine knees to injections of autologous blood. J Bone Joint Surg Am 1967; 49: 285-298
25 Roosendaal G, TeKoppele JM, Vianen ME. Blood-induced joint damage: a canine in vivo study. Arthritis Rheum 1999; 42: 1033-1039
26 Hooiveld M, Roosendaal G, Vianen M. et al. Blood-induced joint damage: longterm effects in vitro and in vivo. J Rheumatol 2003; 30: 339-344
27 Jansen NWD, Roosendaal G, Wenting MJG. et al. Very rapid clearance after a joint bleed in the canine knee cannot prevent adverse effects on cartilage and synovial tissue. Osteoarthritis Cartilage 2009; 17: 433-440
28 Van Meegeren M. Update on pathogenesis of the bleeding joint: an interplay between inflammatory and degenerative pathways. Haemophilia 2010; 16. (Suppl. 05) Suppl 121-123